Tenofovir-Based Pre-Exposure Prophylaxis for HIV Prevention

Current Opinion in Infectious Diseases - United States
doi 10.1097/qco.0b013e32834ef5ef
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Antiretroviral-Based HIV-1 Prevention: Antiretroviral Treatment and Pre-Exposure Prophylaxis

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Perspectives

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2017English

HIV Pre-Exposure Prophylaxis

CMAJ
Medicine
2014English

Probenecid‐Boosted Tenofovir: A PBPK Model Informed Strategy for On‐demand HIV Pre‐exposure Prophylaxis

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2019English

The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

Tenofovir Pre-Exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time Is Now

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

Evidence-Based Study of Medication Compliance Project in Hiv Prevention Using Pre-Exposure Prophylaxis (Prep) Antivirals for HIV-Negative Males

English

Comparing Pharmacologic Measures of Tenofovir Exposure in a U.S. Pre-Exposure Prophylaxis Randomized Trial

PLoS ONE
Multidisciplinary
2018English

HIV Pre-Exposure Prophylaxis (PrEP): Effective but Controversial

Trends in Urology & Men's Health
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy